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Multistage Models of Carcinogenesis
by P. Armitage*
The simple multistage model ofcarcinogenesis is outlined. It provides a satisfactory explanation ofthe
powerlawfortheageincidence ofmanyformsofepithelial carcinoma, fortheeffects inhumanpopulations
of changing exposures to supposed carcinogenic agents, and for many of the observed effects of applied
carcinogens in animal experiments. In particular, the evidence on the effects of starting and stopping
cigarette smoking suggests that both an early and a late stage may be affected. In the absence of direct
evidence on the nature ofthe cellular changes there is some reluctance to accept a model with more than
two stages, and several forms oftwo-stage models provide good general explanations ofobserved phenom-
ena. Such a model has recently been applied to breast cancer; another approach to this disease, effectively
involving transformations of the time scale, is discussed.
Introduction
Multistage and related models ofcarcinogenesis have
been discussed for about 30 years, and the growth in
the literature has been almost as rapid as the rise of
cancer incidence with age. In a short paper I cannot
attempt a comprehensive review, and I shall aim to
outline the topic in a general way, making more specific
comments about some of the points which happen to
have interested me over this period. More comprehen-
sive reviews of the mathematical theory have been
givenbyArmitage and Doll(1), Whittemore (2), Whitte-
more and Keller (3), and Peto (4) has provided a stim-
ulating general review.
Early Work
The flurry of work in the early 1950s, which led to
the formulation of a number of related models, was
probably motivated by evidence from various sources.
First, there was the epidemiological evidence that the
mortality or incidence rates for many forms of human
cancer increased rapidly with age. This might be a gen-
eraleffect ofaging, thebodybecoming more susceptible
to insults of various sorts, or it might be because car-
cinogenesis is acomplex process requiring time and per-
haps involving several qualitatively different stages.
There were two considerations favoring the second ex-
planation: the fact that people exposed to a high but
short-lived carcinogenic risk (for example from irradia-
tion or industrial hazards) often acquire cancer after a
long period of time; and animal experiments such as
those of Berenblum and Shubik (5) showed that some
chemicals are especially effective either early or late in
the induction process (the present terms forthese being
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"initiators" and "promoters"), suggesting that qualita-
tively different processes were at workduringthe early
and late phases. I shall discuss later some more recent
work on the distinction between ageperse and duration
of exposure to carcinogens.
In the reviews mentioned earlier, fuller descriptions
of some ofthe early models are given than can be pre-
sented here. They include the "multicell" theory of
Fisher and Holloman (6) (requiring a mutationlike
change to a specific number of neighboring cells in a
tissue, and inconsistent with the unicellular nature of
mosttumors); andthe "multistage" or"multihit" models
ofStocks (7) and Nordling(8) (inwhich aspecificnumber
ofchanges in any order are required). The very similar
model of Armitage and Doll (9) introduced the idea of
a specific ordering ofthe changes, so as to accommodate
the evidence from initiation-promotion experiments
and also a number of features of the epidemiology of
human cancer. There was also a series of papers by
Iverson and Arley, starting with one (10) which pos-
tulated a randomly occurring initiating event followed
by a randomly distributed induction period. This rather
general formulation encompasses most of the other
models, since in a multistage model the first stage can
be taken as the initiating event while all subsequent
events are subsumed into the induction period (1).
Derivation of the Basic Model
It will be useful to outline the theory ofthe Armitage-
Doll model in slightly different terms to those of the
original paper.
Suppose that, in a particular tissue, there are N cells
(or cell lines, if they divide) that can potentially expe-
rience carcinogenic transformation. The final develop-
ment ofcancer is the k-th and last ofa series ofsudden
and irreversible changes (or stages) which must take
place in a specific order. The clinical detection of theP. ARMITAGE
disease may be delayed by the period required for the
tumor to grow to adetectable size: we shall assume that
this is a relatively short lag and shall not consider it in
any detail. (Many writers systematically replace the
current time t by t-w, where w is the assumed lag.)
Suppose that, for any cell which has experienced i- 1
changes [which we shall call an (i - 1)-cell], the event
rate for next change is Xi, independent oftime. That is
the probability that the i-th change takes place in (t,
t + dt) is Xidt + o(dt). This defines atime-homogeneous
birth process. We should like to know fit), the event
rate for the k-th change at time t (the process starting
at time 0).
General and particular solutions for this problem are
well-known (11-14) but are algebraically cumbersome.
Fortunately, an approximation is adequate for almost
all purposes. Consider the position for values of t small
enough to make the probabilities of any ofthe changes
in (O,t), in any one cell, very small. We can either take
the limit of the general expression as t -O 0 (13,14), or
use a straightforward argument (9) to show that
f(t) - X1X2...k tk-1 (1) (k - 1)!
The cumulative probability, F(t), thatthek-th change
has taken place by time t is
t ~X1X2...Xktk
F(t) = If(u)du k! (2)
Clearly, Eq. (2) cannot hold indefinitely as t increases.
However, in most cases lifetime values of t will still be
sufficientlysmallforthelimitingassumption (which con-
cerns single cells) to be adequate.
Forthe particular tissue withNcells, the probability
that cancer (i.e., the k-th change) has not appeared by
time t is
1 - G(t) = {1 - F(t)}N
{1 _ A1A2
..
Ak tk)
- exp -
X1X2.... kNtk}
k! tk
= exp { k (3)
Thus, the distribution function G(t) for the time to ap-
pearance of the first cancer is a Weibull distribution,
with a density function
g(t) = G'(t) = atkl- exp {-(aIk)tk}
and hazard function
h(t) = g(t)/{l - G(t)} = ote-1 (4)
We have here the familiar power law. The limiting
approximation on which it depends seems reasonably
secure, since it assumes small rates per cell, but Mool-
gavkar (15) has pointed out that, for some values ofthe
parameters which are plausible for human cancer, it
mayappreciablyoverestimatethehazardtobeexpected
at high ages.
Human Cancer
The age-specific mortality rates for cancers at a par-
ticular site, or more directly the age-specific incidence
rates obtained from cancer registries, can be regarded
as roughly analogous to the hazard functions described
mathematically by Eq. (4), since the denominators of
the rates are the numbers ofpeople alive at the ages in
question. From Eq. (4),
log h(t) = log a + (k - 1) log t (5)
and this linearlog-logrelation has beenwidely observed
for a wide range ofsites and human populations (16,17).
It seems to be the usual finding in most epithelial car-
cinomas, but a variety of quite different relationships
is seen for manynonepithelialtumours and forepithelial
tumours at sex-specific sites (4). The slope in Eq. (5) is
commonly in the range four to six, suggesting there
may be around five to seven discrete stages.
However, there are several reasons for caution. In
the first place, several other diseases show rapidly in-
creasing age-incidence curves, and one would not seek
to explain them all by models of this sort. Secondly, a
power law, with a slope ofk-i, or something very close
to it, could be obtained with fewer than k stages. Sup-
pose some ofthe stages had rates increasing as powers
ofthe time elapsing since the previous stage. Then the
slope k - 1 would be the sum ofthe (power + 1) for all
stages before the last plus the power for the last; for
instance, k - 1 = 4 would arise from five constant rates,
or two linearly increasing rates followed by a constant
rate, or a quadratic rate followed by a linear rate. A
reductio ad absurdum is to postulate one state with
A° toc-; the model then becomes purely tautological.
Two-stage models are discussed below.
Third, a similar effect (of a high slope with a small
number ofstages) will be obtained ifone or more ofthe
event rates increases with age (rather than with time
since last event).
Fourth, the Weibull hazard, Eq. (4), can be obtained
more generally, on the argument (18) that the time to
first tumor in a tissue is the minimum of N random
variables (the time to tumor in the N cells), and that
Eq. (4) is a standard limit ofthe distribution ofminima
in large samples. However, for this limiting form to be
valid there are restrictions on the shape ofthe extreme
left-hand tails of the distributions of the cell-specific
times, namely, that they are power functions like Eq.
(1), and this might be taken to provide at least weak
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support for the multistage theory.
Confidence in amultistage modelmust clearly depend
on wider considerations than the power law. In partic-
ular, we need to consider the effects ofexternal carcin-
ogenic agents, data from animal experiments, and bi-
ological plausibility. These and other topics are taken
up in later sections of the paper.
As already noted, the cancers of sex-specific organs
tend nottofollow the powerlaw. This isunderstandable
since many of these organs are subject to changes in
their hormone dependence at various periods through-
out life or, like the uterine cervix, are affected by
changes in sexual habits. Some tentative explanations
ofage-incidence can often be given in qualitative terms
(9). Some recent quantitative modeling for breast can-
cer, in terms ofatwo-stage model is discussed in a later
section.
Animal Experiments and the Effects
of Applied Carcinogens
In experiments in which animals receive continuous
application of a carcinogenic agent, the time to first
tumor commonly follows a distribution close to the
Weinbull (19,20). Such experiments not only provide a
measure of support for the general theory, but also
enable one to study the dose-response relationship. In
the simple multistage model, suppose that m of the k
stages are affected by the carcinogen, so that, for these
values ofi, Xi = d\oi, where d is dose intensity. Then,
from Eq. (4) andthe definition ofa in Eq. (3), the hazard
function should be proportional to dm. It is common to
find m < k, suggesting that some but not all of the
stages are affected by a particular carcinogen.
Carcinogenic agents may, of course, not be applied
at constant rates, and the question arises how the haz-
ard function h(t) is affected ifaparticular rate constant,
say Xi, is an arbitrary function of time Xi(t), which in
the simplest case might be proportional to the dose in-
tensity ofd(t) of an applied carcinogen. The answer (9)
is that h(t) is proportional to a weighted mean of At(t)
in (O,t), the weight at time T (0 < T < t) being propor-
tional to Ti-(t - T)k-i-1. This means that, for small val-
uesofi(earlystagesaffected), what mattersisthevalue
of Xi(T) at low , whereas for high values of i (say k or
k - 1)the more recentvalues ofXi(T) carrymostweight.
These effects are explored more fully by Whittemore
and Keller (3) and by Day and Brown (21).
Inthis context one could broadlyexplain an initiator-
promoterexperimentbysayingthattheinitiatoraffects
primarily the first step and the promoter primarily a
later step (perhaps the second oftwo). However, Sten-
back et al. (22-24) have shown that the interpretation
ofthese experiments may be complicated by aging and
other effects. Earlier, Peto et al. (25) had carried out
some experiments withregularbenzpyrene applications
to mice, which showed that under these circumstances
theincidence oftumors depended onthetime since start
of exposure and not on age. This result is consistent
with the view that the first stage is affected and that
its enhanced event rate in the presence of benzpyrene
ismuchgreaterthanthenaturalbackground rate. Thus,
whether or not it also affects some late stage(s),
benzpyrene appears at least to "initiate" the first stage.
In contrast with the age-independent effect of an ini-
tiator, however, Stenback et al., in experiments similar
to (but much longer than) those ofBerenblum and Shu-
bik (5), found that the "promoting" effect of a TPA
declined with age, suggesting a systemic aging effect
in the response to TPA. Finally, to illustrate that the
opposite effect is possible, Gray et al. (26) in experi-
ments on radon inhalation by rats, found the incidence
at a fixed time after start of exposure to increase with
age. This is what might be expected if radon affected
the second or a later stage, since with increasing age
at start ofexposure there would be more cells that had
alreadyundergone one ormore ofthe early stages spon-
taneously. We return to the question of age effects in
the next section.
Human Data and Exposure to
Carcinogens
The considerations outlined in the first two para-
graphs of the section titled "Animal experiments and
the effects of applied carcinogens" would be expected
to apply to human exposures as well as to animal ex-
periments. One of the most illuminating examples is
providedbytheeffects ofstartingand stoppingsmoking
at different ages (4, 27-29).
Data from prospective studies, such as the British
and American data analyzed by Doll (16), show that
nonsmokers have a log-log relationship for lung cancer
with a slope k - 1 ofabout four. For cigarette smokers,
the same slope is obtained iftime is measured not from
birth but from the start of smoking. This is reasonable
if smoking enhances one or more of the ki to such high
levels that the naturally occurring changes are very
much less frequent than those induced by smoking.
Consider now the effect of stopping smoking. Smok-
ers who stop retain their high rates, but at a constant
level, perhaps until the nonsmokers' rates rise to that
level. This is precisely what would be expected ifsmok-
ing affected the (k - 1)th of k stages, for there would
be a pool of ex-smokers with (k - 1)-cells, waiting for
the final change which would occur at a constant rate.
In due course, the pool will be augmented by naturally
occurring (k - 1)-cells and the rate will start to rise.
Consider, secondly, the incidence rate at a fixed time
after start of smoking, as a function of age at starting.
The data are sparse but seem to indicate either little
effect of age at starting or at most a rather modest
positive effect. This would be consistent with an early
stage being affected; (ifthe first stage were affected so
that Xl, were increased dramatically by smoking, the
process would effectively start at that point, but if the
second stage were affected the number of 1-cells avail-
able for further transformation would increase approx-
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imately linearly with age at starting). Moreover, gen-
eral considerations about the delay in the effect on a
population ofamarked increase in smokingsuggest that
an early stage is affected.
Thus, different arguments support effects on both
early and late stages. Both effects could, of course, be
present. Some skin-painting experiments with benzpyr-
ene on mice (19) have suggested an incidence propor-
tional to (dose)2, in turn suggesting that two stages are
affected by benzpyrene or that there is one stage with
a quadratic effect. A preliminary analysis by Whitte-
more and Altshuler (30) ofthe study on British doctors
(31) suggested that the incidence rate was proportional
to the number ofcigarettes, which provisionallyimplied
that one state was affected proportionally to dose, i.e.,
that m = 1. However, an analysis (32) of a "reliable"
subset of the doctors' data suggests a response more
than proportional to dose; the estimate of m may be
reduced by errors of measurement of smoking habits;
and the effect ofsmoking on a particular Xi may be less
thanproportionaltothe dailyconsumptionofcigarettes.
The evidence thus points, somewhat loosely, toward the
involvement of two stages.
A useful discussion of the effects of removal of car-
cinogenic exposure in a range ofhuman cancers, as well
as in animal experiments, is given by Day and Brown
(21).
The concept that a carcinogen may affect only some
ofthe rate constants helps us to understand some ofthe
observed interactions betweendifferent carcinogens. In
some instances, as in the interaction between smoking
and asbestos exposure (33), the effects ofthe two agents
appear to be multiplicative. This would be expected if
they acted, with proportionate effects on the rate con-
stants, for two different stages, say the i-th and j-th,
since the hazard function, Eq. (4), involves the product
XiXj. On the other hand, ifboth agents affect the same
rate constant Xi, their effects could well be additive.
Two-Stage Models: Breast Cancer
In the absence of direct biological evidence about a
succession ofstages, models with several (five to seven)
stages have often been regarded as implausible. A two-
stage model with exponential proliferation ofthe 1-cells
has been discussed (34). The exponential growth in the
rate constant for the second stage has much the same
effect as a low-order polynomial and it is not surprising
that the two-stage model with proliferation mimics
fairly closely the multistage model with constant rates.
Othertwo-stage models are detailed elsewhere (35-37).
Moolgavkarand Venzonhave studied ageneralization
ofthe model (39) permitting growth also of the 0-cells
and have been able to fit data for awide range ofhuman
cancers. The model has been adapted for breast cancer
by Moolgavkar, Day, and Stevens (40) who postulate
growth in the rate constant forthefirstinitiation during
puberty (with menarche following alogistic curve), sub-
sequent proliferation of 1-cells with an enhanced rate
duringpregnancy, a reduced rate after menopause, and
a protective effect offirst birth by a subsequent reduc-
tion in 1-cell proliferation. They provide extremely im-
pressive fits to data.
Pike and his colleagues (41,42) have obtained equally
impressivefitswithamodel conceptuallydifferentfrom,
but very similar in its consequences, to that of Mool-
gavkar et al. Pike et al. adopt apowerlaw with an index
k - 1 of 4.5, but assume that "time" (as used in the
formula) is effectively expanded or contracted during a
woman's life. Exposure starts at menarche (for which
again a logistic curve is assumed), "time" moves more
rapidlyduringreproductive life, withatemporary spurt
during pregnancy, a fall after the first birth and a fur-
ther fall after menopause. These authors suggest that
the constancy ofbreast cancer rates in postmenopausal
Japanese women (in contrast to the rise in other pop-
ulation groups) may be an effect of their low weights
and low estrogen levels. The changes in the rate of
passage of "time"are equivalent, in the simple multis-
tagemodel, tothemultiplicationofalltherate constants
by some factor varying throughout a woman's life, and
may be motivated by the view that the rate constants
depend on the rate of metabolism of stem cells, which
may vary in the way indicated. It would, of course, be
a rather strong assumption that all the rate constants
should remain in the same ratios to each other although
varying greatly with time.
Low-Dose Extrapolation
Considerable interest has been expressed in recent
years in the assessment of low-dose carcinogenicity on
the basis of extrapolation toward zero dose from the
results of animal experiments in which high doses of
test substances are used (43). Setting aside the impor-
tant questions ofthe extrapolation from laboratory an-
imal to man, there are serious problems about down-
ward extrapolation within one animal species. The
results depend heavily on the assumed nature of the
dose-response curve at very low doses (44-47).
One plausible and helpful assumption is, however,
suggested by many multistage models. Suppose, as be-
fore, that m stages are affected bythe carcinogen. Since
we are dealing with very low doses it will be inappro-
priate to assume the Xi to be proportional to the dose-
intensity d, because there may well be background ef-
fects, but a linear relation seems reasonable. At fixed
t, therefore, from Eq. (3), the cumulative incidence at
dose d will be
P(d) = 1 - exp {-Hf (oi + Pid)} (6)
where the parameters ai and Pi? absorb the constants
and terms involving t in Eq. (3). A slight generalization
of Eq. (6) is to write
P(d) = 1 - exp {
m
EOidt
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where all the Oi are nonnegative, and this model has
been studied in detail (48-51). In Eq. (7), if01 > 0, the
response curve is essentially linear at low doses. This
restriction will give more "conservative" assessments
(i.e., a given excess risk will be reached at lower doses)
than most or all other models proposed. Now, a maxi-
mum likelihood estimate (50) of 01 may be 0, in which
case asteepercurve willbefitted atlowdoses; however,
some nonzero value of 01 will always be consistent with
the data, and so linear extrapolation can scarcely be
excluded as a reasonable procedure.
Other models have been proposed. Hartley and
Sielken (52,53) generalize Eq. (7) to include time. Corn-
field and his associates (54-56) have studied a multihit
model (i.e., one involving hits occurring in an arbitrary
order), which, with certain assumptions about back-
ground effects, has similar consequences to Eq. (6).
However, Van Ryzin (57) points out that the low-dose
linearity of Eq. (6) depends essentially on the assump-
tion that the Xi are asymptotically linear in d. This lin-
earity would follow if the background incidence were
due to a carcinogenic agent, the dose ofwhich combined
additively with the applied dose. This need not be true.
Biological Evidence and
Conclusions
In the construction of mathematical models for bio-
logical phenomena it is not uncommon to find that the-
ories of quite disparate types provide good fits to the
same data. Discrimination between models must then
depend partly on general biological plausibility and
partly on the ability ofthe models to explain new data.
This is essentially the position with our present topic.
As a statistician I can offer no authoritative guide to
biological mechanisms. There seems little doubt,
though, that the multistage theory, in some form or
another, has provided a useful framework for hypoth-
esis formation and for the design of observational and
experimental studies. A number of experimental biol-
ogists maintain that carcinogenesis is a multistage pro-
cess (the term 'multistep' is often used) (58,59), with
perhaps an initial mutationlike stage ofinitiation being
followed by one ormore steps ofadifferentnature (such
as the activation of an oncogene). Evans and DiPaolo
(60,61) have identified a number ofspecific stages in the
progression of guinea pig fetal cells to neoplasia, such
as morphological transformation, anchorage-independ-
ent growth, colony forming in agar, etc.
Until and unless we obtain direct evidence about the
presence and nature ofintermediate stages, any statis-
tical theory is likely to remain largely unfalsifiable, par-
ticularlyifitis allowed tobemodified withtheflexibility
to which we have become accustomed.
Themain contenders forgenerallyapplicable theories
seem to be (a) the multistage theory, (b) some form of
two-stage theory, and (c) the time-transformation the-
ory ofPike and his colleagues. Until we have clear evi-
dence for more than two states, it seems best to regard
the multistage theory, like the dogmas of certain reli-
gions, as permitting either a literal orafigurative inter-
pretation. That is, one can either assume that there
really are k > 2 separate stages or one can regard some
of the intermediate stages as being fictional shorthand
for a single proliferative stage. There does seem a need
to preserve at least two stages, so that we can distin-
guish between "early" and "late" effects ofcarcinogens.
The explicit two-stage models, with appropriate as-
sumptions about proliferation, seem to explain many of
the known facts. However, the observations on the ef-
fects ofstartingand stoppingsmoking, described above,
suggest that at least three stages are involved for lung
cancer (two affected by smoking and a final stage).
Moreover, the multiplicativity ofthe effects ofasbestos
and radiation with that of smoking suggests at least a
third stage. In any proliferative model, the precise na-
ture ofthe proliferative parts ofthe process is likely to
remain indeterminate until and unless direct biological
observations become available.
The time-transformation model is relatively new and
its full consequences have not, as far as I know, been
explored. In one sense, it avoids some of the assump-
tions ofthe other models, in that the power law can be
invoked as an empirical observation without any ref-
erence to stages. On the other hand, the particular way
in which the response function is modified by changing
circumstances (which we have seen would be equivalent
to changing the rate for each of a number of stages by
the same multiple) seems more specific than is required
by other models, and it is unclear whether the model
provides a suitable explanation for initiator-promoter
data or other data in which an early or a late effect in
indicated.
In many areas ofbiomathematics the ingenuity ofthe
mathematician often seems to run ahead of the ability
ofthe biological scientist to provide the data needed to
validate the mathematical models. In the study of car-
cinogenesis it is encouraging to see, to an increasing
extent, the close cooperation between mathematicians
and statisticians on the one hand, and biologists on the
other, and I believe that in this sort ofcollaboration lies
the key to the solution of some of the problems I have
discussed in this paper.
I am grateful to Mr. Richard Peto for helpful comments on the first
draft of this paper.
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